Reversible posterior encephalopathy syndrome associated with bortezomib

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Abstract

Reversible posterior encephalopathy (RPES) is an uncommon neurological syndrome that is being increasingly reported in association with anti-neoplastic therapies. The first case of reversible posterior encephalopathy associated with the proteosome inhibitor bortezomib is described and the reported experience of the occurrence of RPES with other antineoplastic therapies reviewed. Dysregulation of cerebral vasomotor autoregulation is postulated as the underlying pathophysiology in this case of bortezomib associated RPES.

Keywords: bortezomib; proteosome inhibitor; reversible posterior encephalopathy

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1445-5994.2009.02097.x

Affiliations: Departments of Haematology and

Publication date: January 1, 2010

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more